Zommara M, Swelam S, Raya-Alvarez E, Imaizumi K, Elmahdy A, Alkhudhayri D
    
    
    Front Nutr. 2024; 11:1445484.
  
  
    PMID: 39391681
    
          PMC: 11464469.
    
          DOI: 10.3389/fnut.2024.1445484.
      
 
                                  
  
    Yigit E, Deger O, Korkmaz K, Huner Yigit M, Uydu H, Mercantepe T
    
    
    Nutrients. 2024; 16(12).
  
  
    PMID: 38931216
    
          PMC: 11206409.
    
          DOI: 10.3390/nu16121861.
      
 
                                  
  
    Wang L, Zhang Y, Yu H, Song J, Wang Y
    
    
    Eur Heart J Case Rep. 2023; 7(10):ytad472.
  
  
    PMID: 37854104
    
          PMC: 10580372.
    
          DOI: 10.1093/ehjcr/ytad472.
      
 
                                  
  
    Voloshyna I, Teboul I, Kasselman L, Salama M, Carsons S, DeLeon J
    
    
    Inflamm Res. 2019; 68(9):787-799.
  
  
    PMID: 31227843
    
    
          DOI: 10.1007/s00011-019-01262-8.
      
 
                                  
  
    Xia M, Chen D, Endresz V, Lantos I, Szabo A, Kakkar V
    
    
    PLoS One. 2015; 10(4):e0123393.
  
  
    PMID: 25830298
    
          PMC: 4382319.
    
          DOI: 10.1371/journal.pone.0123393.
      
 
                              
              
                              
                                      
  Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion.
  
    Zanotti I, Greco D, Lusardi G, Zimetti F, Poti F, Arnaboldi L
    
    
    PLoS One. 2013; 8(8):e71572.
  
  
    PMID: 23951193
    
          PMC: 3739729.
    
          DOI: 10.1371/journal.pone.0071572.
      
 
                                          
                                                          
  Adaptive immunity and atherosclerosis: mouse tales in the AJP.
  
    Lichtman A
    
    
    Am J Pathol. 2012; 182(1):5-9.
  
  
    PMID: 23159526
    
          PMC: 3532706.
    
          DOI: 10.1016/j.ajpath.2012.10.006.
      
 
                                          
                                                          
  The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
  
    Davenport P, Tipping P
    
    
    Am J Pathol. 2003; 163(3):1117-25.
  
  
    PMID: 12937153
    
          PMC: 1868277.
    
          DOI: 10.1016/S0002-9440(10)63471-2.
      
 
                                          
                                                          
  Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins.
  
    Amberger A, HALA M, Saurwein-Teissl M, Metzler B, Grubeck-Loebenstein B, Xu Q
    
    
    Mol Med. 1999; 5(2):117-28.
  
  
    PMID: 10203577
    
          PMC: 2230414.
    
      
 
                                          
                                                          
  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.
  
    Caspar-Bauguil S, Tkaczuk J, Haure M, Durand M, Alcouffe J, Thomsen M
    
    
    Biochem J. 1999; 337 ( Pt 2):269-74.
  
  
    PMID: 9882624
    
          PMC: 1219961.
    
      
 
                                          
                                                          
  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
  
    Daugherty A, Pure E, Chen S, Leferovich J, Roselaar S, Rader D
    
    
    J Clin Invest. 1997; 100(6):1575-80.
  
  
    PMID: 9294126
    
          PMC: 508339.
    
          DOI: 10.1172/JCI119681.
      
 
                                          
                                                          
  Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis.
  
    George J, Harats D, Gilburd B, Shoenfeld Y
    
    
    Immunol Res. 1996; 15(4):315-22.
  
  
    PMID: 8988398
    
    
          DOI: 10.1007/BF02935315.
      
 
                                          
                                                          
  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.
  
    Zhou X, Stemme S, Hansson G
    
    
    Am J Pathol. 1996; 149(2):359-66.
  
  
    PMID: 8701976
    
          PMC: 1865326.
    
      
 
                                          
                                                          
  Immunology of atherosclerosis: the promise of mouse models.
  
    Lichtman A, Cybulsky M, Luscinskas F
    
    
    Am J Pathol. 1996; 149(2):351-7.
  
  
    PMID: 8701975
    
          PMC: 1865310.
    
      
 
                                          
                                                          
  Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.
  
    Fyfe A, Qiao J, Lusis A
    
    
    J Clin Invest. 1994; 94(6):2516-20.
  
  
    PMID: 7989611
    
          PMC: 330086.
    
          DOI: 10.1172/JCI117622.
      
 
                                          
                                                          
  CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury.
  
    Hancock W, Adams D, Wyner L, Sayegh M, Karnovsky M
    
    
    Am J Pathol. 1994; 145(5):1008-14.
  
  
    PMID: 7977633
    
          PMC: 1887438.
    
      
 
                                          
                                                          
  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
  
    Palinski W, Miller E, Witztum J
    
    
    Proc Natl Acad Sci U S A. 1995; 92(3):821-5.
  
  
    PMID: 7846059
    
          PMC: 42712.
    
          DOI: 10.1073/pnas.92.3.821.
      
 
                                          
                                                          
  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.
  
    Roselaar S, Schonfeld G, Daugherty A
    
    
    J Clin Invest. 1995; 96(3):1389-94.
  
  
    PMID: 7657813
    
          PMC: 185761.
    
          DOI: 10.1172/JCI118174.
      
 
                                          
                                                          
  Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy.
  
    McManus B, Horley K, Wilson J, Malcom G, Kendall T, Miles R
    
    
    Am J Pathol. 1995; 147(2):293-308.
  
  
    PMID: 7639327
    
          PMC: 1869807.
    
      
 
                                          
                                                          
  Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice.
  
    Emeson E, Manaves V, Singer T, Tabesh M
    
    
    Am J Pathol. 1995; 147(6):1749-58.
  
  
    PMID: 7495299
    
          PMC: 1869960.